Patent · US Active

HDAC inhibitors

US8143445B2 · kind B2 · utility

18Cited by
27References
49Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 1, 2008
Grant dateMar 27, 2012
Priority date—
Expiry dateAug 23, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides the compound having the structure

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.